{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:06:28Z","timestamp":1789070788478,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hemophilia A (HA) is caused by mutations in coagulation\n                    <jats:italic>factor VIII<\/jats:italic>\n                    (\n                    <jats:italic>FVIII<\/jats:italic>\n                    ). Genome editing in conjunction with patient-derived induced pluripotent stem cells (iPSCs) is a promising cell therapy strategy, as it replaces dysfunctional proteins resulting from genetic mutations with normal proteins. However, the low expression level and short half-life of FVIII still remain significant limiting factors in the efficacy of these approaches in HA. Here, we constructed a functionally enhanced\n                    <jats:italic>FVIII<\/jats:italic>\n                    variant, F309S\/E1984V-mutated B domain-deleted (BDD)-\n                    <jats:italic>FVIII<\/jats:italic>\n                    (\n                    <jats:italic>FE-FVIII<\/jats:italic>\n                    ), with increased activity and stability. We inserted\n                    <jats:italic>FE-FVIII<\/jats:italic>\n                    with a human elongation factor-1 alpha (EF1\u03b1) promoter into the\n                    <jats:italic>AAVS1<\/jats:italic>\n                    locus of HA patient-derived iPSCs via CRISPR\/Cas9 (D10A) nickase to ensure expression in any cell type.\n                    <jats:italic>FE-FVIII<\/jats:italic>\n                    was expressed not only in undifferentiated\n                    <jats:italic>FE-FVIII<\/jats:italic>\n                    -inserted (FE-KI) iPSCs but also in endothelial cells (ECs) differentiated from them in vitro. Compared with mice transplanted with wild-type\n                    <jats:italic>BDD-FVIII<\/jats:italic>\n                    -containing ECs, immunocompetent HA mice intravenously transplanted with FE-KI ECs presented a 2.12-fold increase in FVIII activity in the blood and an approximately 20% greater survival rate after hemorrhagic tail injury. For sustained efficacy, FE-KI ECs were subcutaneously transplanted into immunodeficient HA mice, resulting in amelioration of the hemophilia phenotype for more than 3 months. This strategy can improve FVIII function and may provide a universal therapeutic approach for treating HA.\n                  <\/jats:p>","DOI":"10.1038\/s12276-024-01375-z","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:00:22Z","timestamp":1736146822000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs"],"prefix":"10.1038","volume":"57","author":[{"given":"Do-Hun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hwi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Jea","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Woo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-5943","authenticated-orcid":false,"given":"Dae-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-0538","authenticated-orcid":false,"given":"Jong-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-1532","authenticated-orcid":false,"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"1375_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2516.2006.01263.x","volume":"12","author":"F Peyvandi","year":"2006","unstructured":"Peyvandi, F. et al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 12, 82\u201389 (2006).","journal-title":"Haemophilia"},{"key":"1375_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0019-5049.144643","volume":"58","author":"S Palta","year":"2014","unstructured":"Palta, S., Saroa, R. & Palta, A. Overview of the coagulation system. Indian J. Anaesth. 58, 515\u2013523 (2014).","journal-title":"Indian J. Anaesth."},{"key":"1375_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1355-0691.2004.00881.x","volume":"10","author":"DR Globe","year":"2004","unstructured":"Globe, D. R., Curtis, R. G., Koerper, M. A. & Hugs, S. C. Utilization of care in haemophilia: a resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS). Haemophilia 10, 63\u201370 (2004).","journal-title":"Haemophilia"},{"key":"1375_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMoa067659","volume":"357","author":"MJ Manco-Johnson","year":"2007","unstructured":"Manco-Johnson, M. J. et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N. Engl. J. Med 357, 535\u2013544 (2007).","journal-title":"N. Engl. J. Med"},{"key":"1375_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"1375_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","volume":"17","author":"CY Park","year":"2015","unstructured":"Park, C. Y. et al. Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9. Cell Stem Cell 17, 213\u2013220 (2015).","journal-title":"Cell Stem Cell"},{"key":"1375_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrg1617","volume":"6","author":"J Graw","year":"2005","unstructured":"Graw, J. et al. Haemophilia A: from mutation analysis to new therapies. Nat. Rev. Genet 6, 488\u2013501 (2005).","journal-title":"Nat. Rev. Genet"},{"key":"1375_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.stemcr.2019.04.016","volume":"12","author":"CY Park","year":"2019","unstructured":"Park, C. Y., Sung, J. J., Cho, S. R., Kim, J. & Kim, D. W. Universal correction of blood coagulation factor VIII in patient-derived induced pluripotent stem cells using CRISPR\/Cas9. Stem Cell Rep. 12, 1242\u20131249 (2019).","journal-title":"Stem Cell Rep."},{"key":"1375_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0243-1","volume":"51","author":"JJ Sung","year":"2019","unstructured":"Sung, J. J., Park, C. Y., Leem, J. W., Cho, M. S. & Kim, D. W. Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs. Exp. Mol. Med. 51, 1\u20139 (2019).","journal-title":"Exp. Mol. Med."},{"key":"1375_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrg3686","volume":"15","author":"H Kim","year":"2014","unstructured":"Kim, H. & Kim, J. S. A guide to genome engineering with programmable nucleases. Nat. Rev. Genet. 15, 321\u2013334 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"1375_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1375_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D. & Jaenisch, R. Induced pluripotent stem cells meet genome editing. Cell Stem Cell 18, 573\u2013586 (2016).","journal-title":"Cell Stem Cell"},{"key":"1375_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00228-009-0676-x","volume":"65","author":"S Bj\u00f6rkman","year":"2009","unstructured":"Bj\u00f6rkman, S., Folkesson, A. & J\u00f6nsson, S. Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: a population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A. Eur. J. Clin. Pharm. 65, 989\u2013998 (2009).","journal-title":"Eur. J. Clin. Pharm."},{"key":"1375_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/blood-2018-08-872291","volume":"133","author":"AC Weyand","year":"2019","unstructured":"Weyand, A. C. & Pipe, S. W. New therapies for hemophilia. Blood 133, 389\u2013398 (2019).","journal-title":"Blood"},{"key":"1375_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/jth.12076","volume":"11","author":"RT Peters","year":"2013","unstructured":"Peters, R. T. et al. Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein. J. Thromb. Haemost. 11, 132\u2013141 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"1375_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ymeth.2015.12.012","volume":"101","author":"F Oceguera-Yanez","year":"2016","unstructured":"Oceguera-Yanez, F. et al. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods 101, 43\u201355 (2016).","journal-title":"Methods"},{"key":"1375_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"1375_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J. S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1375_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/stem.2577","volume":"35","author":"A Harding","year":"2017","unstructured":"Harding, A. et al. Highly efficient differentiation of endothelial cells from pluripotent stem cells requires the MAPK and the PI3K Pathways. Stem Cells 35, 909\u2013919 (2017).","journal-title":"Stem Cells"},{"key":"1375_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/hae.13507","volume":"24","author":"SW Pipe","year":"2018","unstructured":"Pipe, S. W. Bioengineered molecules for the management of haemophilia: promise and remaining challenges. Haemophilia 24, 68\u201375 (2018).","journal-title":"Haemophilia"},{"key":"1375_CR21","doi-asserted-by":"publisher","first-page":"24121","DOI":"10.1074\/jbc.272.39.24121","volume":"272","author":"M Swaroop","year":"1997","unstructured":"Swaroop, M., Moussalli, M., Pipe, S. W. & Kaufman, R. J. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J. Biol. Chem. 272, 24121\u201324124 (1997).","journal-title":"J. Biol. Chem."},{"key":"1375_CR22","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1182\/blood-2008-02-142158","volume":"112","author":"H Wakabayashi","year":"2008","unstructured":"Wakabayashi, H., Varfaj, F., Deangelis, J. & Fay, P. J. Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface. Blood 112, 2761\u20132769 (2008).","journal-title":"Blood"},{"key":"1375_CR23","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/nprot.2016.129","volume":"11","author":"CY Park","year":"2016","unstructured":"Park, C. Y. et al. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR\/Cas9. Nat. Protoc. 11, 2154\u20132169 (2016).","journal-title":"Nat. Protoc."},{"key":"1375_CR24","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2009-07-232546","volume":"115","author":"T Shahani","year":"2010","unstructured":"Shahani, T. et al. Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool. Blood 115, 4902\u20134909 (2010).","journal-title":"Blood"},{"key":"1375_CR25","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","volume":"81","author":"DD Pittman","year":"1993","unstructured":"Pittman, D. D. et al. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81, 2925\u20132935 (1993).","journal-title":"Blood"},{"key":"1375_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1365-2516.2009.02026.x","volume":"15","author":"SW Pipe","year":"2009","unstructured":"Pipe, S. W. Functional roles of the factor VIII B domain. Haemophilia 15, 1187\u20131196 (2009).","journal-title":"Haemophilia"},{"key":"1375_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/JBM.S103796","volume":"8","author":"K Lieuw","year":"2017","unstructured":"Lieuw, K. Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches? J. Blood Med. 8, 67\u201373 (2017).","journal-title":"J. Blood Med."},{"key":"1375_CR28","first-page":"S3","volume":"8","author":"RJ Kaufman","year":"1997","unstructured":"Kaufman, R. J., Pipe, S. W., Tagliavacca, L., Swaroop, M. & Moussalli, M. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul. Fibrinolysis 8, S3\u2013S14 (1997).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"1375_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1182\/blood-2005-11-4571","volume":"108","author":"M Jacquemin","year":"2006","unstructured":"Jacquemin, M. et al. FVIII production by human lung microvascular endothelial cells. Blood 108, 515\u2013517 (2006).","journal-title":"Blood"},{"key":"1375_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jth.12412","volume":"12","author":"T Shahani","year":"2014","unstructured":"Shahani, T. et al. Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII. J. Thromb. Haemost. 12, 36\u201342 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"1375_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1182\/blood-2015-12-684688","volume":"128","author":"J Pan","year":"2016","unstructured":"Pan, J. et al. Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo. Blood 128, 104\u2013109 (2016).","journal-title":"Blood"},{"key":"1375_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2020.06.007","volume":"27","author":"BK Gage","year":"2020","unstructured":"Gage, B. K. et al. Generation of functional liver sinusoidal endothelial cells from human pluripotent stem-cell-derived venous angioblasts. Cell Stem Cell 27, 254\u2013269.e9 (2020).","journal-title":"Cell Stem Cell"},{"key":"1375_CR33","doi-asserted-by":"publisher","first-page":"110621","DOI":"10.1016\/j.celrep.2022.110621","volume":"39","author":"BK Gage","year":"2022","unstructured":"Gage, B. K., Merlin, S., Olgasi, C., Follenzi, A. & Keller, G. M. Therapeutic correction of hemophilia A by transplantation of hPSC-derived liver sinusoidal endothelial cell progenitors. Cell Rep. 39, 110621 (2022).","journal-title":"Cell Rep."},{"key":"1375_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bbrc.2016.02.083","volume":"472","author":"J Pang","year":"2016","unstructured":"Pang, J. et al. Targeting of the human F8 at the multicopy rDNA locus in Hemophilia A patient-derived iPSCs using TALENickases. Biochem. Biophys. Res. Commun. 472, 144\u2013149 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1375_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.1674","volume":"8","author":"A Lombardo","year":"2011","unstructured":"Lombardo, A. et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat. Methods 8, 861\u2013869 (2011).","journal-title":"Nat. Methods"},{"key":"1375_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3179","volume":"12","author":"M Sadelain","year":"2011","unstructured":"Sadelain, M., Papapetrou, E. P. & Bushman, F. D. Safe harbours for the integration of new DNA in the human genome. Nat. Rev. Cancer 12, 51\u201358 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"1375_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13287-019-1138-8","volume":"10","author":"K Gao","year":"2019","unstructured":"Gao, K. et al. Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells. Stem Cell Res. Ther. 10, 34 (2019).","journal-title":"Stem Cell Res. Ther."}],"updated-by":[{"DOI":"10.1038\/s12276-025-01595-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000}}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01375-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:36:11Z","timestamp":1764743771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01375-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1038\/s12276-024-01375-z","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Figure 2c has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s12276-025-01595-x","URL":"https:\/\/doi.org\/10.1038\/s12276-025-01595-x","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}